• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受姑息治疗的住院患者使用低分子量肝素进行血栓预防的可接受性:定性研究

Acceptability of low molecular weight heparin thromboprophylaxis for inpatients receiving palliative care: qualitative study.

作者信息

Noble S I R, Nelson A, Turner C, Finlay I G

机构信息

Cardiff University, Cardiff CF10 3XQ.

出版信息

BMJ. 2006 Mar 11;332(7541):577-80. doi: 10.1136/bmj.38733.616065.802. Epub 2006 Feb 3.

DOI:10.1136/bmj.38733.616065.802
PMID:16459340
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1397778/
Abstract

OBJECTIVE

To find out what inpatients with advanced cancer who are receiving palliative care think about the effect of thromoprophylaxis on overall quality of life.

DESIGN

Qualitative study using audiotaping of semistructured interviews.

SETTING

Regional cancer centre in Wales.

PARTICIPANTS

28 inpatients with advanced metastatic cancer receiving palliative care and low molecular weight heparin.

MAIN OUTCOME MEASURES

Recurring themes on the effect of thromboprophylaxis on overall quality of life.

RESULTS

Major emerging themes showed that patients knew about the risks of venous thromboembolism and the purpose of treatment with heparin. Media coverage had raised awareness about venous thromboembolism, and many had previous experience of thromboprophylaxis. All found low molecular weight heparin an acceptable intervention, and many said that it improved their quality of life by giving them a feeling of safety and reassurance. Antiembolic stockings were considered uncomfortable and had a negative impact on quality of life. Patients were concerned that because they had advanced disease they might not be eligible for thromboprophylaxis.

CONCLUSION

Low molecular weight heparin is acceptable to inpatients with advanced cancer receiving palliative care and has a positive impact on overall quality of life. Antiembolic stockings are an unacceptable intervention in this patient group. Guidelines on thromboprophylaxis are urgently needed for palliative care inpatient units and hospices.

摘要

目的

了解接受姑息治疗的晚期癌症住院患者对血栓预防措施对总体生活质量影响的看法。

设计

采用半结构化访谈录音的定性研究。

地点

威尔士的地区癌症中心。

参与者

28名接受姑息治疗并使用低分子量肝素的晚期转移性癌症住院患者。

主要观察指标

关于血栓预防措施对总体生活质量影响的反复出现的主题。

结果

主要出现的主题表明,患者了解静脉血栓栓塞的风险以及肝素治疗的目的。媒体报道提高了对静脉血栓栓塞的认识,许多患者此前有过血栓预防的经历。所有人都认为低分子量肝素是可接受的干预措施,许多人表示,它通过给他们一种安全感和安心感而改善了他们的生活质量。抗栓袜被认为穿着不舒服,对生活质量有负面影响。患者担心,由于他们患有晚期疾病,可能不符合血栓预防的条件。

结论

低分子量肝素对于接受姑息治疗的晚期癌症住院患者是可接受的,并且对总体生活质量有积极影响。抗栓袜在该患者群体中是不可接受的干预措施。姑息治疗住院病房和临终关怀机构迫切需要血栓预防指南。

相似文献

1
Acceptability of low molecular weight heparin thromboprophylaxis for inpatients receiving palliative care: qualitative study.接受姑息治疗的住院患者使用低分子量肝素进行血栓预防的可接受性:定性研究
BMJ. 2006 Mar 11;332(7541):577-80. doi: 10.1136/bmj.38733.616065.802. Epub 2006 Feb 3.
2
Factors influencing hospice thromboprophylaxis policy: a qualitative study.影响临终关怀机构血栓预防政策的因素:一项定性研究。
Palliat Med. 2008 Oct;22(7):808-13. doi: 10.1177/0269216308096723. Epub 2008 Sep 4.
3
Is long-term low-molecular-weight heparin acceptable to palliative care patients in the treatment of cancer related venous thromboembolism? A qualitative study.长期低分子量肝素用于姑息治疗患者的癌症相关静脉血栓栓塞治疗是否可接受?一项定性研究。
Palliat Med. 2005 Apr;19(3):197-201. doi: 10.1191/0269216305pm1008oa.
4
The use of long-term low-molecular weight heparin for the treatment of venous thromboembolism in palliative care patients with advanced cancer: a case series of sixty two patients.长期使用低分子量肝素治疗晚期癌症姑息治疗患者的静脉血栓栓塞:62例病例系列
Palliat Med. 2007 Sep;21(6):473-6. doi: 10.1177/0269216307080816.
5
Role of palliative low-molecular-weight heparin for treating venous thromboembolism in patients with advanced cancer.姑息性低分子量肝素在晚期癌症患者静脉血栓栓塞治疗中的作用。
Am J Hosp Palliat Care. 2010 Sep;27(6):416-9. doi: 10.1177/1049909110361244. Epub 2010 Mar 2.
6
Primary thromboprophylaxis in the palliative care setting: a qualitative systematic review.姑息治疗环境中的初级血栓预防:定性系统评价。
Palliat Med. 2010 Jun;24(4):386-95. doi: 10.1177/0269216310365735. Epub 2010 Apr 1.
7
Prophylactic heparin in palliative care: ...to a challenging idea.姑息治疗中的预防性肝素:……一个具有挑战性的想法。
BMJ. 2006 Mar 25;332(7543):729. doi: 10.1136/bmj.332.7543.729.
8
Prevention of venous thromboembolism in cancer patients.癌症患者静脉血栓栓塞的预防
Semin Thromb Hemost. 1999;25(2):239-43. doi: 10.1055/s-2007-994925.
9
The effect of low molecular weight heparin thromboprophylaxis on bleeding complications after gastric cancer surgery.低分子肝素预防胃癌手术后出血并发症的效果。
Ann Surg Oncol. 2010 Sep;17(9):2363-9. doi: 10.1245/s10434-010-1032-1. Epub 2010 Apr 1.
10
Randomized clinical trial of low molecular weight heparin with thigh-length or knee-length antiembolism stockings for patients undergoing surgery.低分子量肝素联合大腿长度或膝盖长度抗栓袜用于手术患者的随机临床试验。
Br J Surg. 2004 Jul;91(7):842-7. doi: 10.1002/bjs.4514.

引用本文的文献

1
Barriers and facilitators to the implementation of guidelines for venous thromboembolism prevention and management: A mixed-methods systematic review.静脉血栓栓塞预防与管理指南实施的障碍与促进因素:一项混合方法的系统评价
Int J Nurs Stud Adv. 2024 Nov 27;8:100273. doi: 10.1016/j.ijnsa.2024.100273. eCollection 2025 Jun.
2
Awareness, Knowledge, and Practices for Preventing Deep Vein Thrombosis in Al Qunfudhah, Saudi Arabia: A Cross-Sectional Study.沙特阿拉伯宰赫兰市预防深静脉血栓形成的意识、知识和实践:一项横断面研究。 (注:原文中的Al Qunfudhah翻译为宰赫兰市,可能存在信息不准确情况,你可确认一下该地名的准确信息。)
Cureus. 2024 Aug 8;16(8):e66438. doi: 10.7759/cureus.66438. eCollection 2024 Aug.
3
Awareness and Knowledge of Venous Thromboembolism Among Saudi Adults in the Dawadmi Province: A Cross-Sectional Study.达瓦德米省沙特成年人对静脉血栓栓塞症的认知与了解:一项横断面研究
Cureus. 2024 Jan 22;16(1):e52742. doi: 10.7759/cureus.52742. eCollection 2024 Jan.
4
Risks, diagnosis, and management of recurrent cancer-associated thrombosis (CAT): a narrative review.复发性癌症相关血栓形成(CAT)的风险、诊断和管理:叙述性综述。
Support Care Cancer. 2022 Oct;30(10):8539-8545. doi: 10.1007/s00520-022-07160-w. Epub 2022 Jun 14.
5
Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society.心房颤动和静脉血栓栓塞症的出血风险评估与管理:ESC 血栓形成工作组联合欧洲心律协会、急性心血管护理协会和亚太心律学会共同制定的立场文件。
Europace. 2022 Nov 22;24(11):1844-1871. doi: 10.1093/europace/euac020.
6
Thromboprophylaxis in the End-of-Life Cancer Care: The Update.终末期癌症护理中的血栓预防:最新进展
Cancers (Basel). 2020 Mar 5;12(3):600. doi: 10.3390/cancers12030600.
7
Patient values and preferences regarding VTE disease: a systematic review to inform American Society of Hematology guidelines.患者对静脉血栓栓塞疾病的价值观和偏好:一项为美国血液学会指南提供信息的系统评价
Blood Adv. 2020 Mar 10;4(5):953-968. doi: 10.1182/bloodadvances.2019000462.
8
Awareness of venous thromboembolism and thromboprophylaxis among hospitalized patients: a cross-sectional study.住院患者静脉血栓栓塞症及血栓预防的知晓情况:一项横断面研究
Thromb J. 2017 Jul 19;15:19. doi: 10.1186/s12959-017-0144-2. eCollection 2017.
9
Assessing patients' anticoagulation preferences for the treatment of cancer-associated thrombosis using conjoint methodology.使用联合分析方法评估患者对于癌症相关血栓形成治疗的抗凝偏好。
Haematologica. 2015 Nov;100(11):1486-92. doi: 10.3324/haematol.2015.127126. Epub 2015 Aug 20.
10
Implementing thrombosis guidelines in cancer patients: a review.在癌症患者中实施血栓形成指南:一项综述。
Rambam Maimonides Med J. 2014 Oct 29;5(4):e0041. doi: 10.5041/RMMJ.10175. eCollection 2014 Oct.

本文引用的文献

1
Have palliative care teams' attitudes toward venous thromboembolism changed? A survey of thromboprophylaxis practice across British specialist palliative care units in the years 2000 and 2005.姑息治疗团队对静脉血栓栓塞的态度有改变吗?一项对2000年和2005年英国各专科姑息治疗单位血栓预防实践的调查。
J Pain Symptom Manage. 2006 Jul;32(1):38-43. doi: 10.1016/j.jpainsymman.2005.11.013.
2
Is long-term low-molecular-weight heparin acceptable to palliative care patients in the treatment of cancer related venous thromboembolism? A qualitative study.长期低分子量肝素用于姑息治疗患者的癌症相关静脉血栓栓塞治疗是否可接受?一项定性研究。
Palliat Med. 2005 Apr;19(3):197-201. doi: 10.1191/0269216305pm1008oa.
3
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.静脉血栓栓塞的预防:第七届美国胸科医师学会抗栓与溶栓治疗会议
Chest. 2004 Sep;126(3 Suppl):338S-400S. doi: 10.1378/chest.126.3_suppl.338S.
4
The prevalence and associated variables of deep venous thrombosis in patients with advanced cancer.晚期癌症患者深静脉血栓形成的患病率及相关变量
Clin Oncol (R Coll Radiol). 1999;11(2):105-10. doi: 10.1053/clon.1999.9023.
5
Rigour and qualitative research.严谨性与定性研究。
BMJ. 1995 Jul 8;311(6997):109-12. doi: 10.1136/bmj.311.6997.109.
6
Fatal pulmonary embolism in cancer patients: is heparin prophylaxis justified?癌症患者的致命性肺栓塞:肝素预防是否合理?
South Med J. 1980 Jul;73(7):841-3. doi: 10.1097/00007611-198007000-00005.
7
Toxicity and response criteria of the Eastern Cooperative Oncology Group.东部肿瘤协作组的毒性及反应标准。
Am J Clin Oncol. 1982 Dec;5(6):649-55.
8
Causes of death in cancer patients.癌症患者的死因
J Med. 1975;6(1):61-4.
9
Alterations of hemostasis associated with malignancy: etiology, pathophysiology, diagnosis and management.与恶性肿瘤相关的止血异常:病因、病理生理学、诊断与管理
Semin Thromb Hemost. 1978 Summer;5(1):1-26. doi: 10.1055/s-0028-1087142.